Integrated Filing — IndAS

General information about company
Scrip Code	532406
NSE Symbol	AVANTEL
MSEI Symbol	NOTLISTED
ISIN	INE005B01027
Name of company	AVANTEL LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	26-Apr-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	18-Apr-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	26-Apr-2025   11:00:00
End date and time of board meeting	26-Apr-2025   14:45:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	492613000	2491262000
	Other income	4822000	17881000
	Total income	497435000	2509143000
2	Expenses
(a)	Cost of materials consumed	123133000	837364000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	8842000	-198062000
(d)	Employee benefit expense	133151000	539548000
(e)	Finance costs	6594000	30458000
(f)	Depreciation, depletion and amortisation expense	29357000	118035000
(f)	Other Expenses
1	Other Expenses	111451000	387399000
	Total other expenses	111451000	387399000
	Total expenses	412528000	1714742000
3	Total profit before exceptional items and tax	84907000	794401000
4	Exceptional items	0	0
5	Total profit before tax	84907000	794401000
6	Tax expense
7	Current tax	26271000	232161000
8	Deferred tax	-2206000	-2206000
9	Total tax expenses	24065000	229955000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	60842000	564446000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	60842000	564446000
17	Other comprehensive income net of taxes	-3498000	-3498000
18	Total Comprehensive Income for the period	57344000	560948000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	0	0
	Total profit or loss, attributable to non-controlling interests	0	0
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	0	0
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	0	0
21	Details of equity share capital
	Paid-up equity share capital	489472000	489472000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		0
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	0.25	2.32
	Diluted earnings (loss) per share from continuing operations	0.25	2.3
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	0.25	2.32
	Diluted earnings (loss) per share from continuing and discontinued operations	0.25	2.3
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		1. The fmancial results of the company have been prepared in accordance with Indian Accouting Standards (Ind AS) notified under the companies (Indian Accouting standards) Rules, 2015 as amended by the companies (Indian Accouting standards) (Amendment) rules,2016. n n2. Since the principal customer of the company is an organisation that is controlled by the Government of India, the company has been assured of its Receivables and has not made any provision for loss allowance in the past and as on date. Hence the company has concluded that no provision for loss allowance needs to be made as on March 31, 2025. The company will reassess the model periodically and make the necessary adjustments for loss allowance if any, on case to case basis if required. n n3. Imeds Global Private Limited is wholly owned subsidiary of Avantel Limited. n n4. In the Consolidated Financial results, Employee benefit expenses include Rs. 365.24 Lakhs interms of Avantel nEmployee Stock Option Plan, 2023 for the quarter ending March 31, 2025 and Rs.1456.62 Lakhs for the year nending March 31, 2025. n n5. During the year the company allotted 14,12,270 Equity Shares on December 26, 2024, 44,390 Equity Shares on January 27,2025 and 9,580 Equity Shares on February 26,2025, the options allotted to the employees in terms of Avantel Employee Stock Option Plan, 2023. n n6. The Board of Directors has recommended a fmal dividend of Rs. 0.20 per equity share of Rs. 2/- each for the year ended 31 st March, 2025. n n7. The aforementioned results are reviewed by the Audit Committee of the Board and susequently taken on record by the board of directors at its meeting held on April 26, 2025. n n8. Figures for the previous year/period have been regrouped / reclassified where ever necessary to confirm to the current year's/ period's presentation n n9. The results for the year ended March 31,2025 are also available on the BSE Limited and National Stock Exchange of India Limited websites and on the Company's website.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	1103626000
	Capital work-in-progress	45429000
	Investment property	0
	Goodwill	0
	Other intangible assets	0
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	29336000
	Total non-current financial assets	29336000
	Deferred tax assets (net)	4511000
	Other non-current assets	43182000
	Total non-current assets	1226084000
2	Current assets
	Inventories	604524000
	Current financial asset
	Current investments	0
	Trade receivables, current	712390000
	Cash and cash equivalents	19889000
	Bank balance other than cash and cash equivalents	57775000
	Loans, current	0
	Other current financial assets	7086000
	Total current financial assets	797140000
	Current tax assets (net)	40000
	Other current assets	272678000
	Total current assets	1674382000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	2900466000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	489478000
	Other equity	1882983000
	Total equity attributable to owners of parent	2372461000
	Non controlling interest	0
	Total equity	2372461000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	120000000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	52187000
	Total non-current financial liabilities	172187000
	Provisions, non-current	9801000
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	181988000
	Current liabilities
	Current financial liabilities
	Borrowings, current	91093000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	13890000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	27628000
	Total Trade payable	41518000
	Other current financial liabilities	175420000
	Total current financial liabilities	308031000
	Other current liabilities	29412000
	Provisions, current	0
	Current tax liabilities (Net)	8574000
	Deferred government grants, Current	0
	Total current liabilities	346017000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	528005000
	Total equity and liabilites	2900466000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Communications and signal processing products	496189000	2502458000
2	Health Care	1246000	6685000
	Total Segment Revenue	497435000	2509143000
	Less: Inter segment revenue	0	0
	Revenue from operations	497435000	2509143000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Communications and signal processing products	95675000	827156000
2	Health Care	-10768000	-32755000
	Total Profit before tax	84907000	794401000
	i. Finance cost	0	0
	ii. Other Unallocable Expenditure net off Unallocable income	0	0
	Profit before tax	84907000	794401000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Communications and signal processing products	2677565000	2677565000
2	Health Care	222901000	222901000
	Total Segment Asset	2900466000	2900466000
	Un-allocable Assets	0	0
	Net Segment Asset	2900466000	2900466000
4	Segment Liabilities
	Segment Liabilities
1	Communications and signal processing products	497449000	497449000
2	Health Care	30556000	30556000
	Total Segment Liabilities	528005000	528005000
	Un-allocable Liabilities	0	0
	Net Segment Liabilities	528005000	528005000
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss	3498000	3498000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	-3498000	-3498000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			794401000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			30458000
	Adjustments for decrease (increase) in inventories			-144131000
	Adjustments for decrease (increase) in trade receivables, current			-70630000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-50827000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			-1086000
	Adjustments for other financial assets, current			0
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-16866000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			490000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			118035000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			3712000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			9041000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			0
	Adjustments for interest income			0
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-4484000
	Other adjustments for non-cash items			136221000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			9933000
	Net cash flows from (used in) operations			804334000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			305436000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			498898000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			4709000
	Purchase of property, plant and equipment			783856000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			9517000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			197091000
	Net cash flows from (used in) investing activities	-572539000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			73312000
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			120000000
	Repayments of borrowings			23946000
	Payments of lease liabilities			0
	Dividends paid			48654000
	Interest paid			23425000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-14861000
	Net cash flows from (used in) financing activities			82426000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			8785000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			8785000
	Cash and cash equivalents cash flow statement at beginning of period			11104000
	Cash and cash equivalents cash flow statement at end of period			19889000